Introduction to CEUS for Abdominal Applications: watch here
Introduction to CEUS for Echocardiography: watch here
Special thanks to ICUS Board Member Bev Gorman, the Intersocietal Accreditation Commission, and speakers Cyndi Peterson and Pam Burgess.
The ICUS Bubble Blog showcases real-life CEUS experiences from around the world, with a special focus on how CEUS impacts individual patients and their care.
by Dr. Lisa Johnson
Resident, Department of Radiology, University of Washington, Seattle, WA
Ms. S is a 64-year old Cambodian woman with chronic active hepatitis B currently being treated with tenofivir alafenamide fumarate, a medication to treat the viral infection of her liver.
She has no radiologic or laboratory evidence of cirrhosis and has been undergoing screening abdominal ultrasounds every six months according to international guidelines due to her increased risk for liver cancer given the diagnosis of hepatitis B, which have been unremarkable. Her most recent right upper quadrant ultrasound demonstrated as an incidental finding a newly appeared solid oval area in the midportion of the right kidney without internal vascularity.
